Bryan SHIRLEY, Plaintiff-Appellant, v. PRECISION CASTPARTS CORP., Wyman-Gordon Forgings, L.P., Wyman-Gordon Company, and Wyman-Gordon Forgings, Inc., Defendants-Appellees.
No. 12-20544.
United States Court of Appeals, Fifth Circuit.
Aug. 12, 2013.
675
Robert Michael Moore (argued), Law Office of R. Michael Moore, Houston, TX, for Defendants-Appellees.
Before WIENER, DENNIS, and OWEN, Circuit Judges.
WIENER, Circuit Judge:
Plaintiff-Appellant Bryan Shirley appeals the district court‘s summary judgment that dismissed his claims against
I. FACTS AND PROCEEDING
A. Facts
For twelve years, Shirley worked for Wyman-Gordon Forgings, L.P. (“W-G“) as an operator of the largest extrusion press in the world. Although he had taken Vicodin as prescribed by his doctor for a long time to manage the pain from various work-related injuries, Shirley began visiting physicians at other pain clinics to collect additional prescriptions for the same drug. He did not inform those physicians of his other prescriptions.
Under W-G‘s drug-free workplace policy, any employee who develops a problem with drugs or alcohol may confidentially inform the company‘s human resources (“HR“) manager to pursue treatment. Under that policy, however, an employee “who rejects treatment or who leaves a treatment program prior to being properly discharged will be terminated.”
Following a near overdose in November 2009, Shirley requested medical leave from W-G. Its HR representative, Alan Barnett, granted the requested leave so that Shirley could be treated for the addiction. On December 3, with the blessing of his employer, Shirley checked into Memorial Hermann Prevention and Recovery Center in Houston to begin such treatment.
Treatment for drug addiction involves two distinct, sequential components. In the first step, the patient must detoxify,
On December 5, after successfully detoxifying, Shirley requested that he be discharged, albeit against the recommendation of his treating physician at Memorial Hermann, Dr. Mike Leath. Shirley felt overly confined by the program and resisted efforts to substitute a non-opiate pain reliever for the Vicodin. Believing him to be in denial about his addiction and his dim prospects for recovery without inpatient treatment, Dr. Leath described Shirley‘s discharge prognosis as “guarded” and provided him with a discharge plan under which he was to obtain treatment from his primary care physician, Dr. David Hoefer.
On December 9, Shirley visited Dr. Hoefer, who released him to return to work. On his return, HR representative Barnett informed Shirley that his early departure from Memorial Hermann was grounds for termination under W-G‘s drug-free workplace policy; however, Barnett permitted Shirley to reenter Memorial Hermann to complete his treatment. He was advised that he would be welcomed back to work if he successfully completed his course of treatment at Memorial Hermann.
Shirley accepted W-G‘s offer of a second chance and admitted himself to Memorial Hermann‘s residential program on December 11. He tested positive for hydrocodone on readmission, and he admits that he had taken Vicodin following his initial discharge days earlier, but he insists only in prescribed doses. After only one day of detox, Shirley again checked himself out of the Memorial Hermann program. This time, Dr. Leath‘s discharge note stated that Shirley had completed detox, but had not completed treatment.
On December 14, W-G fired Shirley for twice failing to complete the Memorial Hermann treatment program.
B. Procedural History
Shirley sued the Defendants in district court, alleging that W-G violated the ADA and FMLA when it fired him. The Defendants filed a summary judgment motion addressing both claims, which the court granted. It held that (1) the ADA‘s exclusion of current drug users applied to Shirley, and he was not otherwise protected by the Act‘s safe harbor provision, and (2) the FMLA did not protect him from termination following his violation of W-G‘s drug-free workplace policy. Shirley timely filed a notice of appeal.
II. ANALYSIS
A. ADA Claim
The ADA prohibits employers from discriminating against a “qualified individual on the basis of disability.”2 A “qualified individual” is “an individual who, with or without reasonable accommodation, can perform the essential functions of the employment position that such individual holds or desires.”3
The ADA contains a safe harbor provision in
Notwithstanding this safe harbor exception to the ADA‘s drug-use exclusion, an employer may “adopt or administer reasonable policies or procedures ... designed to ensure that an individual described in paragraph (1) or (2) is no longer engaging in the illegal use of drugs.”7
To make out a prima facie case, Shirley had to show, inter alia, that he was a qualified individual within the intendment of the ADA.8 He challenges the district court‘s conclusion that he failed to bear this burden, asserting that the court erred both in applying the statutory exclusion to him and in holding that he was ineligible for the safe harbor.
1. Section 12114(a)
Although
Shirley nevertheless contends that, current user or otherwise, he is not excluded from ADA coverage by
2. Section 12114(b)
Failing to escape the conclusion that he was “currently engaging” in illegal drug use and was fired “on the basis of such use,” Shirley contends, in the alternative, that he qualifies for the safe harbor under
Again, the district court was correct. As we noted in Zenor v. El Paso Healthcare Sys., Ltd., “the mere fact that an employee has entered a rehabilitation program does not automatically bring that employee within the safe harbor‘s protection.”15 Instead,
Ultimately, courts must determine eligibility for safe harbor “on a case-by-case basis,” asking whether “the circumstances of the plaintiff‘s drug use and recovery justify a reasonable belief that drug use is no longer a problem.”22 As the district court noted, Shirley‘s refusal to complete an inpatient treatment program, his insistence that he remain on an opiate pain reliever, and his continued use of Vicodin following detox “support[ed] a reasonable belief that continued drug use was still an on-going problem at the time [W-G] terminated his employment.” Shirley fails to rebut any of the evidence proffered by his employer and does not otherwise offer evidence of his own sufficient to raise a jury question.23 As he did not establish the existence of a genuine dispute of material fact, summary judgment was appropriate.24
B. FMLA Claim
Shirley also claims that his firing violated his rights under the FMLA. The statute guarantees eligible employees up to twelve weeks of leave during any twelve-month period to attend to various family and medical issues.25 The FMLA contains both prescriptive provisions that create a series of entitlements or substantive rights and proscriptive provisions that protect employees from retaliation or discrimination based on their exercise of those rights.26 Shirley‘s claimed right to return to work after his qualified absence27 is a substantive right within the first category.28
That right is not unlimited, however: An employee is not entitled to “any right, benefit, or position of employment other than any right, benefit, or position to which the employee would have been entitled had the employee not taken the leave.”29 Department of Labor regula-
Our opinion in Nero v. Industrial Molding Corp.35 is not to the contrary. There, having accepted that
As a legitimate cause for termination would preclude his FMLA claim, Shirley had to present evidence sufficient to raise a jury question that W-G‘s stated reason for firing him—violation of its drug-free workplace policy—was pretextual. He suggests that W-G misapplied the policy provision that subjects to termination any employee “who rejects treatment or who leaves a treatment program prior to being properly discharged,” thereby raising the specter of pretext. Shirley would have us parse the policy‘s language and conclude that he did not actually leave the “treatment program” early because he never began the second step, i.e., “treatment,” of Memorial Hermann‘s two-step program in the first place, having begun only the first, or “detox,” step. He insists that the “treatment” was always contemplated to be with his primary care doctor. W-G counters that “treatment program” refers to the entire program—both the detox step and the post-detox treatment step—and that Shirley violated W-G‘s policy when he began but did not complete the treatment program at Memorial Hermann.
W-G is correct, so Shirley‘s claim is unavailing. He initially discharged himself from Memorial Hermann against the advice of his treating physician there, returned to work with a clearance from his primary care physician only, and was timely advised by W-G that his premature departure from Memorial Hermann rendered him subject to termination. Yet he was gratuitously given another chance! He was directed to admit himself a second time and complete the treatment regimen. Readmit himself he did, but finish treatment he did not: Shirley checked himself out after only a single day in the “residential program,” insisting that outpatient treatment with his personal physician was all that he required. Only then was he fired for violating the company‘s drug-free workplace policy.
To suppose, then, that Shirley was denied a right to which he was entitled strains credulity to the breaking point. Even after W-G clarified any ambiguity in its policy and gave Shirley a second chance to comply, he failed—refused!—to do so. W-G‘s interpretation of its policy is probably the correct one; it is certainly not so unreasonable as to invite any inference of pretext in the reason it gave for Shirley‘s termination. Shirley has offered no evidence of discriminatory application of W-G‘s drug-free workplace policy,39 of hostility toward Shirley‘s decision to take medical leave,40 or of his employer‘s reluctance to abide more generally by the FMLA‘s dictates. His allegations and evidence are insufficient to survive summary judgment on his FMLA claim, as no reasonable jury could find that he was denied reinstatement for any reason other than his refusal to continue his FMLA leave period for the express purpose for which it was taken, viz., completing his drug dependency treatment at Memorial Hermann.
III. CONCLUSION
We affirm the judgment of the district court for essentially the reasons set forth
AFFIRMED.
WIENER, Circuit Judge
